Scholarlink

Background <p>Cardiothoracic surgeries such as CABG, valve replacement, and thoracotomy are associated with significant postoperative pain, for which opioids remain the primary treatment despite notable adverse effects and tolerance. Magnesium, an NMDA receptor antagonist with analgesic and cardioprotective properties, has been suggested as a perioperative adjuvant to improve pain control. This systematic review and meta-analysis examined the efficacy and safety of perioperative magnesium for postoperative pain relief in adult cardiothoracic surgery patients.</p> Methods <p>The review followed PRISMA guidelines and was registered with PROSPERO (CRD420251049449). A search was conducted in PubMed, EMBASE, Scopus, and CENTRAL up to 14 May 2025 for randomized controlled trials comparing perioperative magnesium with placebo or other analgesics in adult patients undergoing cardiothoracic surgery. Pain scores, opioid consumption (MME), time to rescue analgesia, length of hospital stay, and adverse events were analyzed. Random-effects meta-analyses were performed using R Studio (v4.3.2) with mean difference (MD) or risk ratio (RR) and 95% confidence intervals (CI).</p> Results <p>Ten RCTs involving 1,140 participants were included. Magnesium significantly reduced pain intensity compared with placebo at 24&#xa0;h postoperatively (MD − 0.85, 95% CI: −1.53 to − 0.16), although the effect did not reach the minimal clinically important difference. No significant differences were observed when magnesium was compared with active analgesics. For all other outcomes, including opioid consumption (MME), time to first rescue analgesia, and length of hospital stay, no significant differences were found in pooled analyses versus either placebo or other analgesics. Heterogeneity was substantial across most outcomes (I² &gt; 75%), and no major adverse events were reported.</p> Conclusion <p>Perioperative magnesium shows small and safe analgesic effects after cardiothoracic surgery, but the clinical relevance remains uncertain due to substantial heterogeneity and variable dosing. Further robust trials are needed to define its efficacy and optimal use.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy and safety of perioperative magnesium on postoperative pain in adult patients undergoing cardiothoracic surgeries- a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月7日

查看全文
  • R. K. Swetha,
  • Balasubramaniam Gayathri,
  • Madhumitha Haridoss,
  • Deepakraj Kuppuraman,
  • Sananthya karthikeyan

摘要

Background

Cardiothoracic surgeries such as CABG, valve replacement, and thoracotomy are associated with significant postoperative pain, for which opioids remain the primary treatment despite notable adverse effects and tolerance. Magnesium, an NMDA receptor antagonist with analgesic and cardioprotective properties, has been suggested as a perioperative adjuvant to improve pain control. This systematic review and meta-analysis examined the efficacy and safety of perioperative magnesium for postoperative pain relief in adult cardiothoracic surgery patients.

Methods

The review followed PRISMA guidelines and was registered with PROSPERO (CRD420251049449). A search was conducted in PubMed, EMBASE, Scopus, and CENTRAL up to 14 May 2025 for randomized controlled trials comparing perioperative magnesium with placebo or other analgesics in adult patients undergoing cardiothoracic surgery. Pain scores, opioid consumption (MME), time to rescue analgesia, length of hospital stay, and adverse events were analyzed. Random-effects meta-analyses were performed using R Studio (v4.3.2) with mean difference (MD) or risk ratio (RR) and 95% confidence intervals (CI).

Results

Ten RCTs involving 1,140 participants were included. Magnesium significantly reduced pain intensity compared with placebo at 24 h postoperatively (MD − 0.85, 95% CI: −1.53 to − 0.16), although the effect did not reach the minimal clinically important difference. No significant differences were observed when magnesium was compared with active analgesics. For all other outcomes, including opioid consumption (MME), time to first rescue analgesia, and length of hospital stay, no significant differences were found in pooled analyses versus either placebo or other analgesics. Heterogeneity was substantial across most outcomes (I² > 75%), and no major adverse events were reported.

Conclusion

Perioperative magnesium shows small and safe analgesic effects after cardiothoracic surgery, but the clinical relevance remains uncertain due to substantial heterogeneity and variable dosing. Further robust trials are needed to define its efficacy and optimal use.